Vanguard Group’s Trevi Therapeutics TRVI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.1M | Buy |
5,316,691
+1,478,659
| +39% | +$8.09M | ﹤0.01% | 2379 |
|
|
2025
Q1 | $24.1M | Buy |
3,838,032
+328,819
| +9% | +$2.07M | ﹤0.01% | 2426 |
|
|
2024
Q4 | $14.5M | Buy |
3,509,213
+246,832
| +8% | +$1.02M | ﹤0.01% | 2753 |
|
|
2024
Q3 | $10.9M | Buy |
3,262,381
+824,930
| +34% | +$2.76M | ﹤0.01% | 2911 |
|
|
2024
Q2 | $7.26M | Buy |
2,437,451
+133,803
| +6% | +$399K | ﹤0.01% | 3080 |
|
|
2024
Q1 | $7.95M | Buy |
2,303,648
+60,249
| +3% | +$208K | ﹤0.01% | 3092 |
|
|
2023
Q4 | $3.01M | Buy |
2,243,399
+285,524
| +15% | +$383K | ﹤0.01% | 3455 |
|
|
2023
Q3 | $4.27M | Buy |
1,957,875
+44,613
| +2% | +$97.3K | ﹤0.01% | 3315 |
|
|
2023
Q2 | $4.57M | Buy |
1,913,262
+413,511
| +28% | +$988K | ﹤0.01% | 3348 |
|
|
2023
Q1 | $2.77M | Buy |
1,499,751
+60,158
| +4% | +$111K | ﹤0.01% | 3559 |
|
|
2022
Q4 | $2.78M | Buy |
1,439,593
+115,216
| +9% | +$222K | ﹤0.01% | 3544 |
|
|
2022
Q3 | $2.04M | Buy |
1,324,377
+1,087,437
| +459% | +$1.68M | ﹤0.01% | 3734 |
|
|
2022
Q2 | $666K | Buy |
236,940
+84,109
| +55% | +$236K | ﹤0.01% | 4212 |
|
|
2022
Q1 | $336K | Buy |
152,831
+10,780
| +8% | +$23.7K | ﹤0.01% | 4456 |
|
|
2021
Q4 | $111K | Buy |
142,051
+5,502
| +4% | +$4.3K | ﹤0.01% | 4607 |
|
|
2021
Q3 | $192K | Buy |
136,549
+3,334
| +3% | +$4.69K | ﹤0.01% | 4490 |
|
|
2021
Q2 | $300K | Hold |
133,215
| – | – | ﹤0.01% | 4328 |
|
|
2021
Q1 | $361K | Hold |
133,215
| – | – | ﹤0.01% | 4181 |
|
|
2020
Q4 | $322K | Hold |
133,215
| – | – | ﹤0.01% | 4030 |
|
|
2020
Q3 | $537K | Sell |
133,215
-5,700
| -4% | -$23K | ﹤0.01% | 3802 |
|
|
2020
Q2 | $914K | Sell |
138,915
-11,517
| -8% | -$75.8K | ﹤0.01% | 3636 |
|
|
2020
Q1 | $495K | Hold |
150,432
| – | – | ﹤0.01% | 3673 |
|
|
2019
Q4 | $564K | Hold |
150,432
| – | – | ﹤0.01% | 3772 |
|
|
2019
Q3 | $677K | Buy |
150,432
+32,341
| +27% | +$146K | ﹤0.01% | 3748 |
|
|
2019
Q2 | $886K | Buy |
+118,091
| New | +$886K | ﹤0.01% | 3706 |
|